Abstract
The bacterium Helicobacter pylori induces gastric inflammation and predisposes to cancer. H. pylori-infected epithelial cells secrete cytokines and chemokines and undergo DNA-damage. We show that the host cell’s mitochondrial apoptosis system contributes to cytokine secretion and DNA-damage in the absence of cell death. H. pylori induced secretion of cytokines/chemokines from epithelial cells, dependent on the mitochondrial apoptosis machinery. A signalling step was identified in the release of mitochondrial Smac/DIABLO, which was required for alternative NF-κB-activation and contributed to chemokine secretion. The bacterial cag-pathogenicity island and bacterial muropeptide triggered mitochondrial host cell signals through the pattern recognition receptor NOD1. H. pylori-induced DNA-damage depended on mitochondrial apoptosis signals and the caspase-activated DNAse. In biopsies from H. pylori-positive patients, we observed a correlation of Smac-levels and inflammation. Non-apoptotic cells in these samples showed evidence of caspase-3-activation, correlating with phosphorylation of the DNA-damage response kinase ATM. Thus, H. pylori activates the mitochondrial apoptosis pathway to a sub-lethal level. During infection, Smac has a cytosolic, pro-inflammatory role in the absence of apoptosis. Further, DNA-damage through sub-lethal mitochondrial signals is likely to contribute to mutagenesis and cancer development.
Subject terms: Cell death and immune response, Infectious diseases, Acute inflammation, Infectious diseases, Cancer
Introduction
Helicobacter pylori (Hp) colonizes the gastric mucus layer of approximately half of the world’s human population. In most cases H. pylori is transmitted in families in childhood and remains associated with its host for decades. An innate and adaptive immune response to the infection ensues, causing chronic gastritis. Infection is mostly asymptomatic but is a major risk factor for gastric and duodenal ulcers and gastric malignancies [1, 2]. H. pylori uses a type IV-secretion system, encoded on the 37 kb cag-pathogenicity island (cag-PAI), to interact closely with gastric epithelial cells and to deliver the cytotoxin associated antigen A (CagA) into the cells [3, 4]. Epithelial cells recognize Hp and activate a number of signalling pathways. Various pattern recognition receptors (PRR) have been implicated, and the cells secrete cytokines/chemokines [5]. This epithelial response likely contributes to the initiation of inflammation. Hp can induce DNA-damage, manifesting as an increased mutation rate [6, 7] but also double-strand breaks (DSBs) [8, 9]. DSBs depended on the type IV-secretion system and received a contribution from host cell factors [8, 10, 11]. DNA-damage induced by direct contact of Hp with gastric epithelial cells may introduce genomic mutations, contributing to cancer development.
Apoptotic cell death can contribute to protecting the replicative niche and to pathogen dissemination. Further, some pathogens can drive and inhibit more than one form of regulated cells death [12]; Hp has also been found to be able to induce pyroptosis in myeloid cells [13]. Many cases of apoptosis are orchestrated through the mitochondrial pathway. In this pathway, an apoptotic stimulus drives the release of the mitochondrial intermembrane space proteins cytochrome c and Smac into the cytosol, where they activate caspases. The intriguing feature of low-level activation of the apoptotic apparatus in the absence of cell death is a recent discovery [14, 15]. Mitochondrial release of cytochrome c does not have to be the point of no return. Rather, during mitochondrial pro-apoptotic signalling, small amounts of cytochrome c may be released, inducing little caspase activity. Small-scale mitochondrial outer membrane permeabilization (‘minority MOMP’ [16]) may however activate the caspase-activated DNAse (CAD), which can introduce persistent DNA-mutations [16, 17].
The apoptosis system often plays a role in infection, and many pathogens have pro- or anti-apoptotic effects, sometimes both [18]. We have recently reported that sub-lethal mitochondrial apoptosis signalling occurs during infection of epithelial cells with intracellular pathogens, from viruses to bacteria and a parasite [19]. Intriguingly, the mitochondrial apoptosis apparatus contributed to cytokine/chemokine secretion. The apoptosis apparatus can be very easily activated. Its low-level activation may therefore be a sensitive way to sense stimuli including infectious agents. High numbers of Hp in cell culture induce apoptosis [20, 21] but apoptosis is not a regular feature during Hp-infection of the stomach. We therefore hypothesized that ‘physiological’, lower numbers of Hp-infection activate the apoptosis pathway in epithelial cells to a sub-lethal level, which may contribute to the inflammatory response of the infected cells.
Results
Inactivation of mitochondrial apoptosis reduces the cytokine response during Hp-infection of epithelial cells
Mitochondrial apoptosis occurs through the activity of Bcl-2-family members. Anti-apoptotic Bcl-2 proteins such as Bcl-XL block apoptosis by binding to the pro-apoptotic members, including the trigger molecules (BH3-only proteins) and the two effectors, Bax and Bak [22]. To test for a potential contribution of the mitochondrial apoptosis system to Hp-induced inflammation, we first infected AGS gastric carcinoma cells with Hp. Infected cells secreted increasing amounts of IL-8 over time, and this was consistently reduced in Bax/Bak-deficient cells (Fig. 1a). In a screen for soluble products secreted by AGS cells upon Hp-infection we also detected CXCL1 and VEGFα (not shown; notably, the inflammasome products IL1β and IL-18 were not detected), and secretion of both was reduced from AGS cells lacking Bax and Bak (Fig. 1b, c; the confirmation of gene-modified cells made in this study is shown in Fig. S1). Chemokine-induction by a clinical Hp-isolate was also reduced (Fig. 1d), as was secretion from HeLa cells lacking Bax and Bak or overexpressing Bcl-XL (Fig. 1e; for some experiments, the results were normalized. The original data from these experiments are all shown in Fig. S8). The same was seen for IL-8 with a second laboratory strain (Fig. 1f). IL-8-secretion from PMA-treated mutant cells was unaltered (Fig. S1o–q).
Supernatants from Hp-infected AGS cells increased neutrophil survival but to a smaller extent when supernatants were from Bax/Bak-deficient cells (Fig. 1g). Neutrophils secreted high amounts of IL-8, and this was reduced in supernatants from Bax/Bak-deficient AGS cells (Fig. 1h). Neutrophil survival in supernatants from Hp-infected HeLa cells showed the same pattern (Fig. 1i), and supernatants from Bax/Bak-deficient HeLa cells induced less neutrophil migration than supernatants from control cells (Fig. 1j). Thus, the mitochondrial apoptosis machinery contributes to chemokine secretion and inflammatory activity in Hp-infected epithelial cells.
Hp-infection induces sub-lethal caspase-activation
High MOI of Hp have been reported to activate caspase-3 [21]. Effector caspase activity during sub-lethal signalling may be too low to be detectable by standard assays [16, 19]. No caspase-3 activation was observed by flow cytometry in Hp-infected AGS or KATOIII cells (Fig. 2a, S2A). No cytotoxicity (LDH-release and Trypan blue uptake) was seen up to 24 h (Fig. 2b, Fig. S2B). Infection up to MOI = 30 did not reduce long-term colony formation in AGS cells. At MOI = 100, there was some reduction, possibly because of the effect of Hp on the cytoskeleton [4]. This was however Bax/Bak independent (Fig. 2c) and therefore independent of mitochondrial apoptosis.
Biotinylated caspase-inhibitory peptide (bio-VAD) was however able to precipitate active caspase-3 from lysates of infected AGS cells (Fig. 2d; staurosporine was used as a positive control). Fluorigenic enzyme assay further showed a moderate but significant activation of effector caspases in lysates from Hp-infected AGS cells (Fig. 2e), which was blocked by the caspase-inhibitor Q-VD-OPh (Fig. S2B). A second gastric cell line, KATOIII, was more sensitive to Hp-induced apoptosis: caspase-3-positive cells were detectable upon infection at an MOI of 30 (Fig. 2f), with a trend to small amounts of DEVD-cleaving activity at MOI = 10 (Fig. 2g), where no caspase-3-positive cells were detected (Fig. 2f) and other measurements of cell death were negative (Fig. 2h, i). In Hp -infected HeLa cells, no active effector caspase was detectable using a reporter line [19] (Fig. S2A, C), and no signal was obtained by enzyme assay (Fig. S2D). No active effector caspases were precipitated from these cells (Fig. S2E), and no cytotoxicity was observed (Fig. S2F). A trend to a higher number of Hela cells with reduced mitochondrial membrane potential was seen (Fig. S2G). A time course over 48 h of infection of AGS control and Bax/Bak-deficient cells with Hp and the read-outs of Trypan blue uptake, LDH-release and DEVD-cleaving activity is shown in Fig. S3.
Low-level, sub-lethal caspase-activation can thus be measured in Hp-infected AGS and KATOIII but not HeLa cells in conditions where the mitochondrial apoptosis apparatus contributed to cytokine secretion. Thus, Hp-infection can generate a sub-lethal signal in the apoptosis pathway.
Hp-infection induces release of Smac
Mitochondrial cytochrome c-release is required for caspase-activation, so small amounts of cytochrome c were likely to be released in the conditions here. Smac is released during (full) apoptosis concomitant with cytochrome c-release [23]; it therefore seemed possible that it is also released upon the Hp-dependent, sub-lethal signals. Smac is a mitochondrial protein but all known molecular functions of Smac are in the cytosol. Cytosolic Smac binds the X-linked inhibitor of apoptosis protein (XIAP), releasing its caspase-inhibitory function. Cytosolic Smac further inactivates cIAP1/2 [24–26]. Small-molecule Smac-mimetics have pro-inflammatory activity, primarily through the activation of alternative NF-κB: inactivation of cIAP1/2 by Smac and Smac-mimetics increases the levels of NIK and triggers alternative NF-κB, detectable as its active form, p52 [26, 27].
We hypothesized that Smac is released during Hp -infection, and a physiological function of Smac may be NF-κB-activation in pathogen-recognition. Increasing doses of Hp caused progressive loss of Smac but not cytochrome c from wt but not Bax/Bak-deficient AGS cells (Fig. 3a–c). By immunostaining, mitochondria of Hp-infected wt but not Bax/Bak-deficient cells showed cytochrome c but little Smac-fluorescence, indicating preferential loss of mitochondrial Smac (Fig. 3d, S4A). We further measured the loss of Smac and cytochrome c in AGS cells single-Bax or -Bak-deficient by microscopy. As shown in Fig. S4B, there was a trend towards a loss of both Smac and cytochrome c in wt cells and in cells lacking Bax but not AGS cells lacking Bak, suggesting it is Bak-activation that drives this loss. Subcellular fractionation showed detectable release of both Smac and cytochrome c into the cytosol of Hp-infected cells (Fig. 3e). A similar effect was observed by measuring total immunofluorescence in KATOIII cells; a trend to Bax/Bak-independent reduction in cytochrome c-fluorescence was also noted in these cells (Fig. 3f, Fig. S4C). In HeLa cells, we observed mitochondrial loss of Smac-GFP but retention of cytochrome c during Hp-infection (Fig. S4G) and found Bax/Bak-dependent loss of Smac and Bax/Bak-independent decrease in cytochrome c-levels (Fig. S4H). There was no detectable loss of mitochondrial membrane potential or mitochondrial mass during Hp-infection of AGS or KATOIII cells (Fig. S4D, E).
The results strongly suggest that Smac is released due to the sub-lethal action of Bax/Bak upon Hp-infection and is degraded in the cytosol. Cytosolic Smac is degraded by the proteasome [28]. During apoptosis, caspases counter-regulate degradation [23], probably through proteasome-inhibition [29]. We reproduced this effect: Smac was released from mitochondria by staurosporine-treatment, and Smac was lost in the presence of caspase-inhibitor (Fig. S4I). The low activity of caspases induced by Hp is likely insufficient for proteasomal inhibition, and therefore cytosolic Smac is degraded. Proteasome inhibition protected Smac from degradation (Fig. S4J). These results indicate that Hp-infection induces Bax/Bak-dependent, non-apoptotic mitochondrial Smac-release.
Smac triggers the activation of NF-κB p100
When experimentally expressed in the cytosol, Smac stimulates alternative NF-κB, as do small molecule Smac-mimetics [26, 30]. We hypothesized that Smac, released from mitochondria during sub-lethal apoptosis signalling, has the same activity. The activation of alternative NF-κB during Hp-infection (processing of p100 to p52), has been described in vitro, as has been its role in gene-deficient mice in vivo [31, 32]. We confirmed NF-κB p100-processing (Fig. 4a). Processing was not seen in Bax/Bak-deficient AGS (Fig. 4a) or HeLa (Fig. S5A) cells. Deletion of Smac reduced p100-processing in AGS (Fig. 4b, S5B), KATOIII (Fig. 4c) and HeLa cells (Fig. S5A; normal p100-processing in response to Smac-mimetic in Bax/Bak and Smac-mutant AGS cells was confirmed, Fig. S1M, N). Phosphorylation of NF-κB p65, i.e. classical NF-κB-signalling, was unaltered (Fig. S5C). We further performed reporter assays in HeLa cells. An NFκB-reporter construct was introduced into control, Bax/Bak-deficient and Smac-deficient cells. These cells showed induction of the reporter upon infection with Hp, and this induction was smaller in Bax/Bak and in Smac-deficient cells (Fig. S5D).
Smac-mimetic-signalling involves the inhibition of cIAP1/2, activating NIK and IKKα [26]. As predicted, KATOIII cells lacking IKKα showed no p100-processing (Fig. 4c). Hp-infection reduced cIAP1 but not XIAP-levels, depending on Smac in KATOIII cells (Fig. 4d, S5E). There was no clear difference in cIAP2-levels in KATOIII cells, and no reproducible loss of cIAP1/2 in AGS or HeLa cells (not shown). In AGS cells infected with the G27-strain, a contribution of Smac to IL-8-secretion was seen at an early time point (6 h, Fig. 4e) but not later on (18 h; not shown). Restoring Smac-expression in the Smac-deficient AGS cells also restored IL-8-secretion (Fig. 4f). Upon infection with the clinical isolate, chemokine secretion at 18 h also required a Smac-contribution (Fig. 4g). In HeLa cells, Smac-deficiency reduced secretion of IL-8 and CXCL1 (Fig. 4h) as well as migration-inducing capacity towards neutrophils (Fig. 4i). Thus, Hp causes the Bax/Bak-dependent release of Smac, which provides a major part of the p100-processing signal, and which contributes to chemokine secretion and neutrophil attraction.
Hp -induced DNA-damage is due to sub-lethal apoptosis signalling
Hp-infection can cause DNA-strand breaks, which may contribute to malignant transformation [8]. Sub-lethal apoptosis signalling can activate the caspase-activated DNAse (CAD), causing DNA-damage and inducing permanent mutations [16]. CAD is activated by the caspase-mediated cleavage of its inhibitor ICAD [33]. Activation of CAD has been described in the published situations of sub-lethal apoptosis signalling, and the CAD-dependent DNA-damage response, detectable as the phosphorylation of the histone H2AX (γH2AX), is a very sensitive way to detect sub-lethal apoptosis signalling [16, 19].
We hypothesized that sub-lethal apoptosis signalling may contribute to the DNA-damage during Hp-infection. As reported, there was a clear γH2AX-response in Hp-infected AGS cells. This response was almost abrogated in CAD-deficient cells (Fig. 5a, S6A,B; two bacterial strains were used). The γH2AX-response was also reduced in Bax/Bak-deficient AGS cells (Fig. 5a, S6A). To test for actual DNA-damage, we scored infected AGS cells for micronuclei, which can form when a cell with damaged genomic DNA goes through mitosis [34, 35]. Hp-infection of AGS cells caused the CAD-dependent formation of micronuclei (Fig. 5b). The γH2AX-signal was abolished by the deletion of CAD in KATOIII (Fig. 5c) and HeLa cells (Fig. 5d, e) and not detectable in HeLa cells when caspase activity was inhibited or mitochondrial apoptosis had been disabled (Bax/Bak-deficiency or Bcl-XL-overexpression, Fig. 5e, S6C,D). The γH2AX-signal was not seen in cells deficient in caspase-9, while individual caspase-3- or caspase-7-deficiency did not block the signal (Fig. 5f). Thus, Hp-infection induces DNA-damage and a DNA-damage-response through the sub-lethal activation of the mitochondrial apoptosis apparatus and CAD. Both caspase-3 and -7 appear to be able to activate CAD downstream of caspase-9.
Upstream signals in the engagement of mitochondria
Our results show that Hp-recognition by epithelial cells generates a signal that triggers the release of mitochondrial Smac. To approach the question of the upstream signals, we analysed bacterial factors and host cell receptor candidates. We infected AGS or HeLa cells with Hp-mutants lacking CagA, the Cag-pathogenicity island (PAI) or the adhesion protein BabA. As has been reported, the appearance of γH2AX and the activation of alternative NF-κB depended on the PAI and BabA but not CagA (Fig. S7A–D) [8, 31, 36]. Two receptor systems can mediate the PAI-dependent recognition of Hp in human cells. The TIFA-signalling axis acts as a recognition machinery of the LPS biosynthesis precursor, heptose-1,7-bisphosphate [37, 38], and NOD1 responds to Hp peptidoglycan fragments (muropeptides) [39].
Loss of Smac upon Hp-infection (Fig. 6a, S7E, G, H) and γH2AX-induction (Fig. S7G) were unaltered in TIFA-deficient cells (as a control in HeLa cells, Smac-loss is also shown, Fig. 6a, S7E). We used a chemical inhibitor of NOD1, ML-130 [40]. This inhibitor blocked release (Fig. 6a, S7E) and loss of Smac (Fig. 6b, c), as well as the activation of NF-κB p100 (Fig. 6b, c) and the γH2AX-signal in AGS cells (Fig. 6b, c). The NOD1-inhibitor reduced p100-upregulation, the appearance of p52 and Smac-loss also in HeLa cells (Fig. S7F). Genomic deletion of the NOD1-gene further reduced IL-8-secretion (Fig. S4F) and the γH2AX-DNA-damage response in AGS cells (Fig. 6d). The signaling pathway upstream of mitochondria therefore appears to originate from NOD1 while TIFA, which is required for the activation of classical NF-κB upon Hp-infection, does not partake in mitochondrial signaling. The ligands of NOD1 are Hp peptidoglycan-fragments (muropeptides). While it has not been possible to generate a peptidoglycan-deficient strain of Hp, a strain deficient in lytic transglycosylase activity, which has a defect in the release of the NOD1-binding muropeptides, has been found to be less active in NOD1-dependent induction of IL-8 in AGS cells [39]. This strain had lost the ability to generate a γH2AX-signal upon infection of AGS cells (Fig. 6e), consistent with the interpretation that NOD1 is required to drive this signalling.
Evidence of sub-lethal apoptosis signaling in Hp-patients
We analyzed biopsies from a cohort of Hp-positive gastritis patients. Most patients showed histological evidence of gastritis (Sydney score for acute inflammation of 1–2, Fig. 7a, d, for chronic inflammation 1–3, Fig. 7e). In a substantial number of samples we detected epithelial cells in the gastric glands that gave a clear signal when stained with an antibody recognizing active caspase-3. The frequency of positive cells varied (mostly in the range of 5–50%); typically, large fractions of the cells in the neck region of the gastric glands, where Hp is commonly seen, were positive (Fig. 7a). Hardly any apoptoses were observed (under 1% of cells). No correlation between caspase-3-activation and inflammatory score was observed (Fig. 7b). Parietal cells gave a generally stronger Smac-signal, and the corpus (more parietal cells) was more strongly positive than the antrum (Fig. 7c). Intriguingly, the overall proportion of Smac-positive cells inversely correlated with acute and chronic inflammatory scores, with a similar trend for acute inflammation in the antrum and chronic inflammation in the body separately (Fig. 7d, e). This is reminiscent of the Smac content of cell lines, where Hp -infection reduced Smac. Biopsies from patients without (known) acute gastric inflammation, who had undergone gastric resection during bariatric surgery, were also stained and showed low levels of caspase-3-positive cells (Fig. 7b). In vitro, the most sensitive parameter of sub-lethal signals in the apoptosis pathway has been the DNA-damage response. We tested for DNA-damage response in these patient samples, using phosphorylation of ATM-kinase as a read-out. The signal for pATM showed a clear correlation with the level of cells expressing active caspase-3 (Fig. 7f), consistent with the model where Hp activates caspase-3 to a sub-lethal level of activity, causing DNA-damage and a DNA-damage response.
Discussion
It is clear now that the mitochondrial apoptosis pathway can be triggered to sub-lethal activity but potential physiological roles and their pathways need to be worked out. This study shows that the pathway is triggered by a PRR during infection with a common bacterium, which causes chronic and oncogenic inflammation. It identifies a signalling role for Smac: Smac can be released in non-apoptotic cells and assume the pro-inflammatory role previously identified for Smac-mimetics. The results further suggest that sub-lethal mitochondrial apoptosis signals contribute to the development of infection-associated cancer.
We detected release of small amounts of both cytochrome c and Smac upon Hp-infection, and the data suggest that Smac was preferentially released. How such preferential release of Smac is achieved is unclear: during apoptosis, Smac-release occurs alongside the release of cytochrome c [23]. However, loss of the mitochondrial fission protein Drp1 reduced the release of cytochrome c but not Smac [41], and the apoptotic release of cytochrome c itself is far from clear [42]. Release of Smac has been reported in human cells infected with Shigella bacteria, where it has been suggested to block anti-bacterial immunity through interference with XIAP [43].
Most information of a pro-inflammatory role of Smac comes from investigations of Smac-mimetics, with some studies of experimental overexpression of Smac. In these studies, a dramatic cIAP-downregulation has regularly been observed (see for example [26]). We observed a relatively small loss of cIAP1 only in one of the cell lines we used, although deletion and reconstitution experiments clearly identified a role of Smac in IL-8-secretion upon Hp-infection. It seems conceivable that the generation of a signal activating alternative NF-κB through Smac may occur in the absence of obvious loss of cIAPs, especially if classical NF-κB is activated at the same time. Indeed, it may be the case that the massive loss of these proteins that are seen during Smac-mimetic stimulation is not necessarily what occurs during perhaps physiological, small stimuli. Further, cIAP-levels may be concurrently up-regulated by other signalling pathways, such as canonical NF-κB [44] or, as recently shown for cIAP2 and Hp-infection, through Brd4 [45].
Our data suggest a model where peptidoglycan, whose delivery required PAI but not CagA, as well as bacterial adhesion, stimulate NOD1 as the most upstream sensor. It has been reported earlier that p100/p52-processing [31] as well as the induction of DNA-damage [8, 36] depend on these bacterial factors. Additional factors are likely involved: at least one of our clinical isolates had reduced activity in activating sub-lethal apoptosis signals. Which such factors may be involved is uncertain; it is known Hp can evolve heavily in individual subjects over time and alter for instance its pro-inflammatory activity [46]. How Hp regulates its activities in the human stomach during long-term infection is an intriguing question, and how this is linked to the induction of sub-lethal signals in the mitochondrial apoptosis pathway will need careful future investigation.
It may be surprising that a PRR, a receptor from a class much better known to activate NF-κB and interferon responses, triggers the mitochondrial apoptosis apparatus. However, there are many examples where in experimental situations PRR can cause apoptotic cell death. This has been found for NOD1 itself [47], for a number of Toll-like receptors [48–51], RIG-I and Mda5 [52] and cGAS/STING [53]. It seems conceivable that the generation of sub-lethal apoptosis signals is an activity that is common to a number of pattern recognition receptors and that adds to immune activation.
The direct introduction of DNA-damage by Hp required the mitochondrial apoptosis apparatus. Our results suggest that mitochondrial signals have physiological functions in signalling immune alert in non-professional immune cells. At the same time, chronic signalling through Smac and NF-κB may contribute to malignant transformation, as has been proposed for modifications to XIAP [54]. The accompanying DNA-damage may be a necessary side effect that is outweighed by the benefit of Smac-dependent immune activation. The carcinogenic effect of bacterial infection is small: Hp -infection is a significant but small risk factor for gastric carcinoma, and cancer development typically takes many years. This supports the interpretation that indeed CAD-induced DNA-damage remains at an acceptable level, given the probably more important immune function of Smac-release.
Material and methods
Cell lines and cell culture
AGS cells (89090402-1VL, Sigma-Aldrich) were cultured in Ham´s F-12K medium (21-127-022, Thermo Fisher Scientific), HeLa and KATOIII in RPMI 1640 medium (61870044, Life Technologies) with 10% FCS. CRISPR-Cas9 (52961, Addgene) genome editing was done as described previously [19]; cells deficient in CAD, Bax/Bak were established using the gRNAs described [19]. Guide RNAs used here were Smac1 (TTAGTAGTGAAGCATTGATG), Smac2 (GTGCAATAGGAACCGCACAC), TIFA1 (GAAACTCCCTTCCAGCGAAG) and TIFA2 (CATCCTGGCCAGTTGCAGTG) caspase-3 (ATTGTGGAATTGATGCGTGA), caspase-7 (TGTACTGATATGTAGGCACT) (Human CRISPR Knockout Pooled Library (Brunello) [55]); NOD1 (GCAACTCGCAGATGCCTACG), Ikkα (ACAGACGTTCCCGAAGCCGCCGG), Caspase-9 (ATCTCCTGCTTAGAGGACAC) was designed using GPP web portal (Broad Institute). HeLa cell lines overexpressing Bcl-XL have been described [19]. Reconstitution of human Smac in AGS Smac knockout cells (Smac2 gRNA used for Knockout) was done by cloning human Smac (mutated in the gRNA sequence) into lentiviral construct pEF1-GW-Puro-hSmac. All knock outs were tested by western blotting (Fig. S1a–k). NOD1 knockout was confirmed by sequencing (Fig. S1k).
Bacterial culture and infection
Hp strains G27, T26695 and isogenic mutants were provided by Wolfgang Fischer and Rainer Haas, LMU Munich. The slt-deficient and its parental strain were from Ivo Gomperts Boneca, Paris. Bacteria were cultured at 37 °C, 5% O2 and streaked freshly the day prior to infection. Bacteria were diluted in Brucella browth. Infection was controlled microscopically.
Antibodies
Antibodies were against active caspase-3 (clone C92-605, 559565, BD; clone5A1E, Cell Signaling), phospho-ATM (S1981, Abcam), beta-tubulin (9F3,2128 L, NEB), α-tubulin (Sigma-Aldrich, #t9026), Bax (Cell Signaling #2772), Bak (Cell Signaling #21105), Bcl-XL (54H6, Cell Signaling), CAD (PA5-19913, Thermo Fisher, and CAD (F11), SantaCruz sc-374067), caspase-3 (Cell Signaling #9662), caspase-7 (Cell Signaling #9494), caspase-9 (Cell Signaling, #9502), cIAP1 (D5G9, Cell Signaling), cytochrome c (D18C7, Cell Signaling), cytochrome c (6H2B4, Cell Signaling), GAPDH (MAB374, Millipore), γH2AX (2577 L, Cell Signaling), IKKα (Cell Signaling #2682), NF-κB p100/p52 (18D10, Cell Signaling), phospho-NF-κB p65 (93H1, Cell Signaling), Smac (#15108 or #2954, Cell Signaling), TIFA (CSB-PA839301LA01HU, Cusabio), VDAC (Cell Signaling #4661), XIAP (Cell Signaling #14334). Secondary antibodies: anti mouse IgG-Cy5 (715-175-151, Dianova), donkey anti rabbit IgG-Alexa Fluor647 (711-605-152, Dianova), anti rabbit IgG-Alexa488 (711-545-152, Dianova), anti mouse IG-HRP (115-035-166, Dianova), anti rabbit-HRP (A6667, Sigma).
Reagents
DAPI, etoposide, Hoechst, PMA, staurosporine (Sigma); Fugene (Promega), LCL161 (Active Biochem), Mito Tracker Deep Red (Life Technologies), ML-130 (Tocris), Z-VAD-fmk (Gentaur) were used as indicated.
ELISA
We identified soluble AGS-products in a screen by bead array (Eve Technologies, Calgary). Cytokines in supernatants were measured by ELISA: IL-8 (Biolegend), CXCL-1 (RnD Systems), VEGF-α (Boster Bio).
Primary peripheral blood neutrophils
Neutrophils were obtained from healthy adult volunteers by negative selection with a magnetic cell separation system (EasySep kit, Stem Cell Technologies). Purity of cell preparations was confirmed by Giemsa staining.
Transwell migration assay
A 24-well transwell system (3 µm pore, Corning Costar) was used. HeLa cell supernatants (400 µl) were added into the lower chamber, and 3.5 × 105 freshly isolated neutrophils in 200 µl complete medium were placed into the upper chamber. Negative controls (medium) and positive controls (human IL-8 (5 ng/ml)) were included. After 75 min incubation migration was stopped. Cells in the lower chamber were harvested and counted (CASY cell counter, Omni Life Science).
Neutrophil function
Neutrophils (3 × 105/300 µl) were co-incubated with supernatants from AGS cells infected with Hp G27 (diluted 1:2) for 24 h. Cells were harvested, stained with Annexin V-FITC (Thermo Fisher) and Live/ Dead Fixable Far Red Dye (Thermo Fisher), fixed in 4% PFA (Morphisto) and analyzed by flow cytometry (FACS Calibur, BD). Supernatants from neutrophils were collected for ELISA.
Caspase activity assays
Cells (1.5 × 105) were seeded and infected in duplicates in 6-well plates, fixed in 4% formalin and stained for active caspase-3. Caspase-3 reporter cells have been described [19]. Analyses were performed with a FACS Calibur (BD). For enzyme assay, cells were pooled from duplicates and lysed (buffer 9803, Cell Signaling/ protease inhibitors (Roche)). Ten µl of lysate were incubated with reaction buffer (90 µl, MDB buffer, 11 µM Ac-DEVD-AMC (Bachem), 100 µg/ml BSA, 0,1% CHAPS) in triplicates. Analyses were performed with a Spark 10 M (Tecan). For precipitation of active caspases, biotinylated VAD-fmk (Santa Cruz) was added 3 h before harvesting. Cells were lysed with RIPA buffer. Aliquots were boiled at 95 °C in Laemmli buffer. Supernatants were incubated with neutravidin beads (Thermo Fischer) at 4 °C overnight. The beads were washed with RIPA buffer. Laemmli buffer was added and beads were boiled, followed by Western blotting for active caspase-3.
LDH-release assay
Cells (6 × 104) were seeded in 24-well plates. LDH concentration in filtered supernatants was measured by cytotoxicity detection kit (Roche). Cytotoxicity was calculated as ratio of experiment value after background reduction divided by Triton X-100 lysed cells.
Colony assay
Cells (1.5 × 105) were seeded in 6-well plates. Following infection, cells were counted and plated (500 cells/well) in triplicates (medium contained 100U/ml Ampicillin). Seven days later, colonies were stained with cristal violet and counted.
Immunofluorescence
Cells were fixed on IBIDI-slides and permeabilized with 0.2% Triton-X100 in PBS (Smac and cytochrome c) or with methanol at −20 °C (γH2AX). Staining was done by consecutive incubation with primary and secondary antibody in the same buffer. Nuclei were stained with Hoechst. Pictures were taken blinded with a Zeiss LSM 880 (Smac, cytochrome c) or with a Keyence BZ-9000 (γH2AX). γH2AX dots per cell were counted with ImageJ. In KATOIII cells, corrected total cell fluorescence (CTCF) was determined with ImageJ. Photos of at least 50 Smac and cytochrome c-co-stained cells per condition and per experiment were acquired (Zeiss LSM 880). CTCF was calculated using the formula CTCF = integrated density − (area of selected cell x mean fluorescence of background readings).
Western blotting
Cells (1.5 × 105) were seeded in 6-well plates. Cells were lysed with Laemmli buffer in the wells. Samples were sonicated and heated to 95 °C before loading to SDS PAGE. PVDF membranes were blocked with 5% milk. Proteins were detected with ECL substrate. Signal intensity was calculated with ImageJ. Full length original western blots are provided in Supplementary File 1.
Subcellular fractionation to analyze cytochrome c and Smac subcellular localization
AGS cells containing an empty vector were either mock- or Helicobacter-infected (G27, MOI 100) for 18 h to assess the release of Smac and cytochrome c. Cells were harvested, washed and resuspended in MB-EDTA buffer. Mitochondria were obtained by flashing cells through a 27 G needle using 1 mL syringe as described [56]. Mitochondrial fractions were isolated and supernatants were centrifuged for 60 min at 4 °C and 120,000xg. The resulting supernatants (cytoplasmic fractions) together with mitochondrial fractions were analyzed by immunoblotting using VDAC and α-tubulin as marker proteins for mitochondrial and cytoplasmic fractions.
Micronuclei assay
AGS cells in IBIDI 8 µm microscopy well were fixed with 4% PFA and stained with anti-tubulin antibody and DAPI in 1% BSA/0.1% Tween-20/PBS. Approximately 200 cells per experiment in five pictures (Zeiss LSM 880 confocal microscope) were analyzed in a blinded fashion.
Human stomach samples
Sampling of biopsies from Hp -infected patients was approved by the local ethics board. Thirty-six samples from 18 patients (20x antrum, 16x body) were analyzed. Tissues were blocked and immunostained for Smac, pATM and cleaved caspase-3 using a Dako detection system and counterstained with hematoxcylin. Epithelial cells (at least 400 cells per biopsy) were counted in high power fields of representative areas. Inflammation was scored in H&E stains using the Sydney classification [57].
Statistics
Statistics were calculated with Prism (V7, GraphPad). Unpaired T-test was used when comparing two samples. One-way and two-way ANOVA were used for multiple testing. Normalized data were analyzed by one-sample T-test. All statistical tests were performed two-sided. Linear regression was used to compare biopsies from Hp-infected patients.
Supplementary information
Acknowledgements
We thank Julia Huber and Luisa Braun for expert technical assistance, Rainer Haas and Wolfgang Fischer for providing the Hp parental and mutant strains and Dr Ivo Gomperts Boneca for providing the slt-mutant strain. We also thank the Tumour Bank Freiburg for providing the biopsy samples.
Author contributions
Conceptualization: GH, BD; Formal analysis: BD; Funding acquisition: GH; Investigation: BD, MTB, AH, LF, JV, BE, AM, PB, KA, JH, CWK, SK, IP, AW; Methodology: GH, BD, AH, JV, BE, SK; Project administration: GH, BD; Resources: GH, SK, PB, JH; Supervision: GH; Validation: GH, SK, KA; Visualization: GH, BD, KA; Writing –original draft: GH, BD; Writing–review and editing: MTB, AH, LF, JV, BE, AM, PB, KA, JH, CWK, SK, AW.
Funding
This work was supported by the MOTI-VATE graduate school of the Freiburg University Medical School (grant to BD) and the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) through the IMM-PACT-Program for Clinician Scientists– 413517907 (grant to MTB) and a grant to GH (HA 2128). Part of the project was supported by the Wilhelm Sander-Stiftung (2019.151.1). Open Access funding enabled and organized by Projekt DEAL.
Data availability
All data supporting the findings of this study are available from the corresponding author upon reasonable request. Information on the human stomach biopsies can be accessed upon request from the CCCF tumour bank Freiburg.
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
Informed patient consent has been obtained. Sampling of biopsies from Hp -infected patients was approved by the local ethics board.
Footnotes
Edited by D. Vaux
The original online version of this article was revised: Due to missing funding information.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Change history
5/16/2022
A Correction to this paper has been published: 10.1038/s41418-022-01019-7
Supplementary information
The online version contains supplementary material available at 10.1038/s41418-022-01009-9.
References
- 1.Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347:1175–86. doi: 10.1056/NEJMra020542. [DOI] [PubMed] [Google Scholar]
- 2.Peek RM, Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002;2:28–37. doi: 10.1038/nrc703. [DOI] [PubMed] [Google Scholar]
- 3.Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science. 2000;287:1497–1500. doi: 10.1126/science.287.5457.1497. [DOI] [PubMed] [Google Scholar]
- 4.Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci USA. 1999;96:14559–64. doi: 10.1073/pnas.96.25.14559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Blosse A, Lehours P, Wilson KT, Gobert AP. Helicobacter: Inflammation, immunology, and vaccines. Helicobacter. 2018;23:e12517. doi: 10.1111/hel.12517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Jenks PJ, Jeremy AH, Robinson PA, Walker MM, Crabtree JE. Long-term infection with Helicobacter felis and inactivation of the tumour suppressor gene p53 cumulatively enhance the gastric mutation frequency in Big Blue transgenic mice. J Pathol. 2003;201:596–602. doi: 10.1002/path.1488. [DOI] [PubMed] [Google Scholar]
- 7.Touati E, Michel V, Thiberge JM, Wuscher N, Huerre M, Labigne A. Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology. 2003;124:1408–19. doi: 10.1016/S0016-5085(03)00266-X. [DOI] [PubMed] [Google Scholar]
- 8.Toller IM, Neelsen KJ, Steger M, Hartung ML, Hottiger MO, Stucki M, et al. Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proc Natl Acad Sci USA. 2011;108:14944–9. doi: 10.1073/pnas.1100959108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Hanada K, Uchida T, Tsukamoto Y, Watada M, Yamaguchi N, Yamamoto K, et al. Helicobacter pylori infection introduces DNA double-strand breaks in host cells. Infect Immun. 2014;82:4182–9. doi: 10.1128/IAI.02368-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hartung ML, Gruber DC, Koch KN, Gruter L, Rehrauer H, Tegtmeyer N, et al. H. pylori-Induced DNA strand breaks are introduced by nucleotide excision repair endonucleases and promote NF-kappaB target gene expression. Cell Rep. 2015;13:70–79. doi: 10.1016/j.celrep.2015.08.074. [DOI] [PubMed] [Google Scholar]
- 11.Bauer M, Nascakova Z, Mihai AI, Cheng PF, Levesque MP, Lampart S, et al. The ALPK1/TIFA/NF-kappaB axis links a bacterial carcinogen to R-loop-induced replication stress. Nat Commun. 2020;11:5117. doi: 10.1038/s41467-020-18857-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Tummers B, Green DR. The evolution of regulated cell death pathways in animals and their evasion by pathogens. Physiol Rev. 2022;102:411–54. doi: 10.1152/physrev.00002.2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Pachathundikandi SK, Muller A, Backert S. Inflammasome activation by Helicobacter pylori and its implications for persistence and immunity. Curr Top Microbiol Immunol. 2016;397:117–31. doi: 10.1007/978-3-319-41171-2_6. [DOI] [PubMed] [Google Scholar]
- 14.Lovric MM, Hawkins CJ. TRAIL treatment provokes mutations in surviving cells. Oncogene. 2010;29:5048–60. doi: 10.1038/onc.2010.242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Orth JD, Loewer A, Lahav G, Mitchison TJ. Prolonged mitotic arrest triggers partial activation of apoptosis, resulting in DNA damage and p53 induction. Mol Biol cell. 2012;23:567–76. doi: 10.1091/mbc.e11-09-0781. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Ichim G, Lopez J, Ahmed SU, Muthalagu N, Giampazolias E, Delgado ME, et al. Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death. Mol cell. 2015;57:860–72. doi: 10.1016/j.molcel.2015.01.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Miles MA, Hawkins CJ. Executioner caspases and CAD are essential for mutagenesis induced by TRAIL or vincristine. Cell death Dis. 2017;8:e3062. doi: 10.1038/cddis.2017.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Hacker G. Apoptosis in infection. Microbes Infect / Inst Pasteur. 2018;20:552–9. doi: 10.1016/j.micinf.2017.10.006. [DOI] [PubMed] [Google Scholar]
- 19.Brokatzky D, Dorflinger B, Haimovici A, Weber A, Kirschnek S, Vier J, et al. A non-death function of the mitochondrial apoptosis apparatus in immunity. EMBO J. 2019;38:e102325. doi: 10.15252/embj.2018100907. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Maeda S, Yoshida H, Mitsuno Y, Hirata Y, Ogura K, Shiratori Y, et al. Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori. Gut. 2002;50:771–8. doi: 10.1136/gut.50.6.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Potthoff A, Ledig S, Martin J, Jandl O, Cornberg M, Obst B, et al. Significance of the Caspase family in Helicobacter pylori induced gastric epithelial apoptosis. Helicobacter. 2002;7:367–77. doi: 10.1046/j.1523-5378.2002.00112.x. [DOI] [PubMed] [Google Scholar]
- 22.Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ, Green DR. The BCL-2 family reunion. Mol cell. 2010;37:299–310. doi: 10.1016/j.molcel.2010.01.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Rehm M, Dussmann H, Prehn JH. Real-time single cell analysis of Smac/DIABLO release during apoptosis. J cell Biol. 2003;162:1031–43. doi: 10.1083/jcb.200303123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell. 2000;102:33–42. doi: 10.1016/S0092-8674(00)00008-8. [DOI] [PubMed] [Google Scholar]
- 25.Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell. 2000;102:43–53. doi: 10.1016/S0092-8674(00)00009-X. [DOI] [PubMed] [Google Scholar]
- 26.Vince JE, Wong WW, Khan N, Feltham R, Chau D, Ahmed AU, et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell. 2007;131:682–93. doi: 10.1016/j.cell.2007.10.037. [DOI] [PubMed] [Google Scholar]
- 27.Silke J, Vucic D. IAP family of cell death and signaling regulators. Methods Enzymol. 2014;545:35–65. doi: 10.1016/B978-0-12-801430-1.00002-0. [DOI] [PubMed] [Google Scholar]
- 28.MacFarlane M, Merrison W, Bratton SB, Cohen GM. Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro. J Biol Chem. 2002;277:36611–6. doi: 10.1074/jbc.M200317200. [DOI] [PubMed] [Google Scholar]
- 29.Sun XM, Butterworth M, MacFarlane M, Dubiel W, Ciechanover A, Cohen GM. Caspase activation inhibits proteasome function during apoptosis. Mol cell. 2004;14:81–93. doi: 10.1016/S1097-2765(04)00156-X. [DOI] [PubMed] [Google Scholar]
- 30.Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P, et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell. 2007;131:669–81. doi: 10.1016/j.cell.2007.10.030. [DOI] [PubMed] [Google Scholar]
- 31.Mejias-Luque R, Zoller J, Anderl F, Loew-Gil E, Vieth M, Adler T, et al. Lymphotoxin beta receptor signalling executes Helicobacter pylori-driven gastric inflammation in a T4SS-dependent manner. Gut. 2017;66:1369–81. doi: 10.1136/gutjnl-2015-310783. [DOI] [PubMed] [Google Scholar]
- 32.Maeda S, Yoshida H, Ogura K, Mitsuno Y, Hirata Y, Yamaji Y, et al. H. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. Gastroenterology. 2000;119:97–108. doi: 10.1053/gast.2000.8540. [DOI] [PubMed] [Google Scholar]
- 33.Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 1998;391:43–50. doi: 10.1038/34112. [DOI] [PubMed] [Google Scholar]
- 34.Harding SM, Benci JL, Irianto J, Discher DE, Minn AJ, Greenberg RA. Mitotic progression following DNA damage enables pattern recognition within micronuclei. Nature. 2017;548:466–70. doi: 10.1038/nature23470. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Mackenzie KJ, Carroll P, Martin CA, Murina O, Fluteau A, Simpson DJ, et al. cGAS surveillance of micronuclei links genome instability to innate immunity. Nature. 2017;548:461–5. doi: 10.1038/nature23449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Koeppel M, Garcia-Alcalde F, Glowinski F, Schlaermann P, Meyer TF. Helicobacter pylori infection causes characteristic DNA damage patterns in human cells. Cell Rep. 2015;11:1703–13. doi: 10.1016/j.celrep.2015.05.030. [DOI] [PubMed] [Google Scholar]
- 37.Stein SC, Faber E, Bats SH, Murillo T, Speidel Y, Coombs N, et al. Helicobacter pylori modulates host cell responses by CagT4SS-dependent translocation of an intermediate metabolite of LPS inner core heptose biosynthesis. PLoS Pathog. 2017;13:e1006514. doi: 10.1371/journal.ppat.1006514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Gall A, Gaudet RG, Gray-Owen SD, Salama NR. TIFA signaling in gastric epithelial cells initiates the cag Type 4 secretion system-dependent innate immune response to Helicobacter pylori infection. mBio. 2017;8:e01168-17. doi: 10.1128/mBio.01168-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol. 2004;5:1166–74. doi: 10.1038/ni1131. [DOI] [PubMed] [Google Scholar]
- 40.Khan PM, Correa RG, Divlianska DB, Peddibhotla S, Sessions EH, Magnuson G, et al. Identification of Inhibitors of NOD1-Induced Nuclear Factor-kappaB Activation. ACS Med Chem Lett. 2011;2:780–5. doi: 10.1021/ml200158b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Ishihara N, Nomura M, Jofuku A, Kato H, Suzuki SO, Masuda K, et al. Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice. Nat cell Biol. 2009;11:958–66. doi: 10.1038/ncb1907. [DOI] [PubMed] [Google Scholar]
- 42.Dewson G. Doughnuts, daisy chains and crescent moons: the quest for the elusive apoptotic pore. EMBO J. 2016;35:371–3. doi: 10.15252/embj.201593723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Andree M, Seeger JM, Schull S, Coutelle O, Wagner-Stippich D, Wiegmann K, et al. BID-dependent release of mitochondrial SMAC dampens XIAP-mediated immunity against Shigella. EMBO J. 2014;33:2171–87. doi: 10.15252/embj.201387244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci USA. 1997;94:10057–62. doi: 10.1073/pnas.94.19.10057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Chen Y, Sheppard D, Dong X, Hu X, Chen M, Chen R, et al. H. pylori infection confers resistance to apoptosis via Brd4-dependent BIRC3 eRNA synthesis. Cell death Dis. 2020;11:667. doi: 10.1038/s41419-020-02894-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Jackson LK, Potter B, Schneider S, Fitzgibbon M, Blair K, Farah H, et al. Helicobacter pylori diversification during chronic infection within a single host generates sub-populations with distinct phenotypes. PLoS Pathog. 2020;16:e1008686. doi: 10.1371/journal.ppat.1008686. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Inohara N, Koseki T, del Peso L, Hu Y, Yee C, Chen S, et al. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J Biol Chem. 1999;274:14560–7. doi: 10.1074/jbc.274.21.14560. [DOI] [PubMed] [Google Scholar]
- 48.Weber A, Kirejczyk Z, Besch R, Potthoff S, Leverkus M, Hacker G. Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells. Cell death Differ. 2010;17:942–51. doi: 10.1038/cdd.2009.190. [DOI] [PubMed] [Google Scholar]
- 49.Ruckdeschel K, Pfaffinger G, Haase R, Sing A, Weighardt H, Hacker G, et al. Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages. J Immunol. 2004;173:3320–8. doi: 10.4049/jimmunol.173.5.3320. [DOI] [PubMed] [Google Scholar]
- 50.Fischer SF, Rehm M, Bauer A, Hofling F, Kirschnek S, Rutz M, et al. Toll-like receptor 9 signaling can sensitize fibroblasts for apoptosis. Immunol Lett. 2005;97:115–22. doi: 10.1016/j.imlet.2004.10.015. [DOI] [PubMed] [Google Scholar]
- 51.Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science. 1999;285:736–9. doi: 10.1126/science.285.5428.736. [DOI] [PubMed] [Google Scholar]
- 52.Besch R, Poeck H, Hohenauer T, Senft D, Hacker G, Berking C, et al. Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. J Clin Investig. 2009;119:2399–411. doi: 10.1172/JCI37155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Gulen MF, Koch U, Haag SM, Schuler F, Apetoh L, Villunger A, et al. Signalling strength determines proapoptotic functions of STING. Nat Commun. 2017;8:427. doi: 10.1038/s41467-017-00573-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Palrasu M, Zaika E, El-Rifai W, Garcia-Buitrago M, Piazuelo MB, Wilson KT, et al. Bacterial CagA protein compromises tumor suppressor mechanisms in gastric epithelial cells. J Clin Investig. 2020;130:2422–34. doi: 10.1172/JCI130015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol. 2016;34:184–91. doi: 10.1038/nbt.3437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Wilfling F, Weber A, Potthoff S, Vogtle FN, Meisinger C, Paschen SA, et al. BH3-only proteins are tail-anchored in the outer mitochondrial membrane and can initiate the activation of Bax. Cell death Differ. 2012;19:1328–36. doi: 10.1038/cdd.2012.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Caselli M, Aleotti A, Barboni A, Alvisi V. Sydney classification for gastritis and Helicobacter pylori. Lancet. 1990;336:1445–6. doi: 10.1016/0140-6736(90)93146-G. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data supporting the findings of this study are available from the corresponding author upon reasonable request. Information on the human stomach biopsies can be accessed upon request from the CCCF tumour bank Freiburg.